Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.48 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Neuphoria Therapeutics (NEUP) Goodwill impairment charges (2026)

Updated

Neuphoria Therapeutics' Goodwill impairment charges was $5.4 million in fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Neuphoria Therapeutics (NEUP) Goodwill impairment charges (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Neuphoria Therapeutics 437.56 Mn 362.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.40 Mn
API Access

Neuphoria Therapeutics Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=NEUP&period=max&api_key=YOUR_API_KEY